Carregant...
Novel Immunotherapeutic Approaches in Head and Neck Cancer
Unresectable recurrent or metastatic head and neck cancer is an incurable disease with survival of approximately 12 months. Head and neck tumors exhibit numerous derangements in the tumor microenvironment that aid in immune evasion and may serve as targets for future therapies. Pembrolizumab is now...
Guardat en:
| Publicat a: | J Cancer Metastasis Treat |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357897/ https://ncbi.nlm.nih.gov/pubmed/32661502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-4722.2019.32 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|